Carbapenem resistance in members of the Enterobacteriaceae is increasing. To evaluate the effects of tigecycline and polymyxin B against carbapenem-non-susceptible pathogens, 89 representative clinical carbapenem-non-susceptible Enterobacteriaceae isolates were recovered from seven hospitals from four cities in China during 2006-2009: 30 Serratia marcescens, 35 Klebsiella pneumoniae, seven Enterobacter cloacae, six Enterobacter aerogenes, five Escherichia coli, four Citrobacter freundii and two Klebsiella oxytoca isolates. Twenty-eight S. marcescens isolates were indistinguishable. The 35 K. pneumoniae isolates belonged to 12 clonal strains. Among the 89 Enterobacteriaceae isolates, 82 produced KPC-2, seven produced IMP (three produced KPC-2 simultaneously), three did not produce any carbapenemases and nine were deficient in porins. Polymyxin B was much more active than tigecycline against carbapenem-nonsusceptible Enterobacteriaceae. The MIC 50 and MIC 90 of imipenem, meropenem, ertapenem, polymyxin B and tigecycline were 8 and 32 mg ml "1 , 8 and 32 mg ml "1 , 16 and 128 mg ml "1 , 0.5 and 16 mg ml "1 , and 4 and 16 mg ml , respectively. Rates of susceptibility to imipenem, meropenem, ertapenem and polymyxin B were 30.0 %, 27.5 %, 2.5 % and 89.2 % by CLSI criteria. The rate of susceptibility to tigecycline was 40 % and 17.5 % by Food and Drug Administration (MIC ¡2 mg ml "1 ) and European Committee on Antimicrobial Susceptibility Testing (MIC ¡1 mg ml "1 ) criteria, respectively. KPC-2-or IMP-producing E. coli transconjugants exhibited reduced susceptibility to carbapenems but were susceptible to polymyxin B and tigecycline with an MIC range of 0.5-2 mg ml "1 , 0.25-2 mg ml "1 , 0.5-4 mg ml "1 , 0.5 mg ml "1 and 0.5-1 mg ml "1 . In conclusion, carbapenem resistance in Enterobacteriaceae is mainly due to production of KPC-2, and polymyxin B is active for the carbapenem-resistant Enterobacteriaceae.
INTRODUCTION
The treatment of serious infections caused by Enterobacteriaceae producing AmpC cephalosporinases or extended-spectrum b-lactamases (ESBLs) depends mainly on carbapenems. Carbapenem resistance appears to be increasing in the Enterobacteriaceae due to multiple mechanisms including the new type of metallo-b-lactamase designated NDM-1 (Yong et al., 2009) . The emergence of carbapenemresistant Enterobacteriaceae severely limits the treatment options. Tigecycline is a new semisynthetic glycylcycline derived from minocycline and exhibits activity against a wide range of aerobic Gram-positive and Gram-negative bacteria, including ESBL-, AmpC-and even carbapenemase-producing Enterobacteriaceae isolates, and anaerobic and atypical pathogens (Hawkey & Finch, 2007; Kelesidis et al., 2008; Morosini et al., 2006; Townsend et al., 2006) . Polymyxin B is an old antibiotic with strong activity against the major Enterobacteriaceae and non-lactose-fermenting Gram-negative bacteria. It has been seldom used and has been replaced by aminoglycosides and quinolones in China since the 1970s because of its potential nephrotoxic and neurotoxic effects. In recent years, multiresistant and panresistant strains of Pseudomonas aeruginosa, Acinetobacter species and Enterobacteriaceae have increased dramatically and polymyxin B is often the only efficient antibiotic. Hence, polymyxin B is used as the last choice for the treatment of infections caused by those strains (Li et al., 2005 (Table 1) . Some of these have been described previously, including 21 S. marcescens (SM1-SM21) (Cai et al., 2008a) , 10 K. pneumoniae (KP1-KP10) (Cai et al., 2008a) , one E. coli (EC01) (Cai et al., 2008a) , one C. freundii (CF1) (Zhang et al., 2008) and one E. cloacae (ECL1) (Cai et al., 2008b) KPC-2-producing isolates, one K. oxytoca (KO2) (Chen et al., 2009a) and one E. cloacae (ECL7) (Chen et al., 2009b) IMPproducing isolate, and two ESBL-or AmpC-producing K. pneumoniae combined with porin deficiency (KP34 and KP35) (Wang et al., 2009 ).
Molecular epidemiology analysis. PFGE and enterobacterial repetitive intergenic consensus-PCR (ERIC-PCR) were performed to analyse the molecular origin and homology of the isolates. PFGE typing was performed by the procedure as described by PulseNet from the US Centers for Disease Control and Prevention website (http:// www.cdc.gov/pulsenet/) in a Rotaphor System 6.0 instrument (Whatman Biometra). The XbaI restriction patterns of genomic DNAs were analysed and interpreted according to the criteria of Tenover et al. (1995) . Total DNAs of S. marcescens isolates were obtained with an Axyprep Bacterial Genomic DNA Miniprep kit (Axygen Scientific) and were used as templates in ERIC-PCR analysis. The PCR primers and PCR conditions were as described by Versalovic et al. (1991) .
Conjugal transfer experiment. Rifampicin-resistant E. coli EC600 (LacZ 2 , Nal R , Rif R ) was used as the recipient strain. A conjugation experiment was carried out in mixed broth cultures as described previously (Cai et al., 2008a) . E. coli transconjugants were selected on Mueller-Hinton agar plates containing 400 mg rifampicin (Sigma) ml 21 plus 0.2 mg meropenem ml 21 .
PCR amplification and DNA sequence analysis of bla genes.
Plasmid DNA from clinical isolates and E. coli transconjugants was used as template in PCR amplification. The primers used to amplify carbapenemase genes bla KPC , bla NMC , bla SME , bla IMI , bla GES , bla IMP-1 , bla IMP-2 , bla VIM-1 , bla VIM-2 and bla OXA-48 (Queenan & Bush, 2007) , ESBL genes bla TEM , bla SHV and bla CTX-M , and plasmidborne AmpC genes (including those encoding MOX-1, MOX-2, CMY-1-CMY-11, LAT-1-LAT-4, BIL-1, DHA-1, DHA-2, AAC, MIR-1, ACT-1 and FOX-1-FOX-5b) (Pérez-Pérez & Hanson, 2002) were as described previously. The reaction was conducted in a Tpersonal thermal cycler (Whatman Biometra). PCR amplification products were purified and directly sequenced using an ABI 3730 Sequencer (Applied Biosystems), and the sequences were compared with the reported sequences from GenBank using the BLASTN program.
SDS-PAGE analysis of outer-membrane proteins (OMPs).
OMPs were isolated as described by Hernández-Allés et al. (1999) . Strains were grown in Mueller-Hinton broth overnight at 37 uC with Table 1 . Distribution of carbapenem-non-susceptible Enterobacteriaceae according to carbapenem-resistance mechanisms and hospital location Organism (n) Carbapenemase and porin deficiency (n) Location/hospital* (n)
shaking. OMP profiles were determined by SDS-PAGE using 11.6 % acrylamide/0.4 % bisacrylamide/0.1 % SDS gels. The gel was run at a constant current with a Mini Protein 3 slab electrophoresis cell (BioRad). The gel was visualized by staining with Coomassie brilliant blue.
Antimicrobial susceptibility testing. The MICs of imipenem (Merck), meropenem (Dainippon Sumitomo Pharma), ertapenem (Merck), polymyxin B (Sigma) and tigecycline (Wyeth) were determined using the agar dilution method according to CLSI (2006) recommendations. E. coli ATCC 25922 was used for quality control.
RESULTS AND DISCUSSION
PFGE and ERIC-PCR typing ( Fig. 1 and Fig. 2 )
From a total of 27 K. pneumoniae isolates from the Second Affiliated Hospital of Zhejiang University (KP1-KP25, KP34 and KP35), seven different PFGE patterns were detected. The PFGE pattern of K. pneumoniae KP11 was identical to that for KP1-KP10, which was reported previously (Cai et al., 2008a 
Transfer of carbapenem resistance
Transfer of carbapenem resistance from all clinical isolates to E. coli EC600 by conjugation was successful except that for K. pneumoniae KP34 and KP35 and E. coli ECO5.
Cefoxitin was used instead of meropenem to suppress the growth of E. coli transconjugants which acquired plasmidmediated AmpC b-lactamase from the three isolates. E. coli transconjugants of KP35 and ECO5 were able to grow on Mueller-Hinton agar plates containing 400 mg rifampicin ml 21 and 16 mg cefoxitin ml
21
.
PCRs and DNA sequence analysis
Among 89 Enterobacteriaceae isolates, bla KPC-2 was detected in 82 and their E. coli transconjugants, bla IMP was detected Fig. 1 . ERIC-PCR patterns of S. marcescens isolates. SM1-SM30, 30 KPC-2-producing S. marcescens isolates; S1-S3, three carbapenem-susceptible S. marcescens isolates that did not produce KPC-2; T1-T3, three E. coli transconjugants of S. marcescens SM1, SM24 and SM27; EC600, E. coli EC600; B, negative control; M, molecular mass standard DL5000 (TaKaRa).
in seven isolates (five IMP-4, one IMP-1 and one IMP-8) and three isolates (K. pneumoniae KP34 and KP35, and E. coli ECO5) were negative for all tested carbapenemase genes. E. cloacae ECL3, C. freundii CF1 and K. oxytoca KO1 were positive for the carbapenemase genes for both KPC-2 and IMP. Several b-lactamase genes of bla TEM , bla SHV-11 or bla SHV-12 , and bla CTX-M-14 or bla CTX-M-3 were prevalent in these isolates, and the majority of them produced more than one b-lactamase. E. coli transconjugants of K. pneumoniae KP35 and E. coli ECO5 produced plasmidborne AmpC DHA-1 and CMY-2, respectively.
The first case of KPC-2 in China was initially reported in a K. pneumoniae isolate from Hangzhou city in 2007 , and subsequently in several isolates of S. marcescens, E. coli, C. freundii and E. cloacae (Cai et al., 2008a, b; Zhang et al., 2007 Zhang et al., , 2008 . In recent years, KPCproducing Enterobacteriaceae have rapidly spread in many Chinese cities (Shen et al., 2009; Wu et al., 2010; Yang et al., 2010) . In our study, KPC-2 was the most commonly found carbapenemase in carbapenem-non-susceptible Enterobacteriaceae (82/89). KPC-2-producing Enterobacteriaceae were isolated from five hospitals in two cities. Though PFGE showed that many isolates from the same hospital were indistinguishable or closely related to each other, interhospital clonal dissemination was not observed. Besides KPC-2, IMP was another carbapenemase detected in these isolates. Among seven IMP-producing isolates, three produced KPC-2 simultaneously. The distribution of MICs for the 89 isolates and their resistance profiles including the production of different enzymes and porin deficiency are shown in Supplementary Table S1 in JMM Online and in Fig. 3 .
SDS-PAGE analysis of OMPs
Among the KPC-producing isolates, the MICs of carbapenems for some of the isolates were extremely high compared to those for the others and the KPC-2 transconjugants. Meanwhile, we also observed that metallo-b-lactamaseproducing isolates exhibited a wide range of carbapenem MICs. In addition, some isolates were resistant to carbapenems but were negative for all tested carbapenemase genes. We suspected that alterations in outer-membrane permeability may be involved in the carbapenem resistance for these three different types of isolates. Therefore, we compared the expression of OMPs in these isolates with that in the lower resistance isolates. We did find 10 isolates (isolates KP10, Fig. 2 . PFGE patterns of chromosomal DNA restriction fragments from carbapenem-nonsusceptible Enterobacteriaceae. KP11-KP33, 23 K. pneumoniae isolates; ECL1-ECL6, six E. cloacae isolates; EA1-EA6, six E. aerogenes isolates; CF1-CF4, four C. freundii isolates; ECO1-ECO4, four E. coli isolates.
KP32, KP32-E, KP34, KP35, ECL1, ECL7, ECO5, CF1 and KO2) that either had abnormally high carbapenem MICs but produced either KPC or metallo-b-lactamases, or were resistant to carbapenems but had no carbapenemases at all. However, porin expression was normal for the two isolates (KP1 and KP33) which either produce metallo-b-lactamases or KPC but without extremely high MIC against carbapenems. It is the porin OmpK36 that was absent in five Klebsiella species, while the OmpK35 was expressed normally. Such results were in line with those from another study in China (Yang et al., 2010) , which showed that 33 out of 49 carbapenem-non-susceptible Enterobacteriaceae isolates did not produce carbapenemase, and 28 out of those 33 isolates had lost or had reduced expression of both porins.
Antimicrobial susceptibility
Enterobacteriaceae isolates exhibited resistance or reduced susceptibility to carbapenems. MICs of carbapenems were distributed over a wide range (1-.256 mg ml
21
). The majority of strains exhibited MICs of carbapenems ranging between 4 and 16 mg ml 21 and a portion showed MICs above 128 mg ml 21 . In general, MICs of ertapenem were one to two dilutions (two-to fourfold) higher than those Table S1 ). Only one strain was chosen from isolates with identical PFGE patterns and b-lactamase production, and MIC 50 , MIC 90 and rates of susceptibility and resistance of imipenem, meropenem, ertapenem, polymyxin B and tigecycline were calculated ( Table 2 ). The rate of susceptibility to imipenem, meropenem and ertapenem was 30.0 %, 27.5 % and 2.5 %, respectively, and that to polymyxin B (S. marcescens isolates were excluded) was 89.2 % by the CLSI criteria for Acinetobacter baumannii species. The rate of susceptibility to tigecycline was 40.0 % and 17.5 % by the Food and Drug Administration (FDA) (MIC ¡2 mg ml
) and European Committee on Antimicrobial Susceptibility Testing (EUCAST) (MIC ¡1 mg ml
) criteria, respectively. KPC-2-or IMPproducing E. coli transconjugants exhibited reduced susceptibility to carbapenems with an MIC range of 0.5-2 mg ml 21 , 0.25-2 mg ml 21 and 0.5-4 mg ml
, but were susceptible to polymyxin B and tigecycline with an MIC range of 0.5 mg ml 21 and 0.5-1 mg ml
. AmpC-producing E. coli transconjugants were susceptible to the five antibiotics. Castanheira et al. (2008) reported that 88.1 % of 104 carbapenemase-producing Enterobacteriaceae isolates were susceptible to polymyxin B and 100 % were susceptible to tigecycline (by the FDA criteria). In another study (Pliatsika et al., 2007) , 109 metallo-b-lactamase-producing Enterobacteriaceae isolates were all susceptible to tigecycline, except only a K. pneumoniae strain, by the FDA criteria. According to the EUCAST criteria, 31 % of Enterobacter species, 89 % of K. pneumoniae and 100 % of E. coli isolates were susceptible and all S. marcescens isolates were intermediate. In the current study, the rate of susceptibility to polymyxin B for carbapenem-non-susceptible isolates (89.2 %) was similar to that in the study of Castanheira et al. (2008) . However, the rate of susceptibility to tigecycline (40.0 %) was much lower than that in both previous studies. The lower susceptibility to tigecyline in our study might be due to the previous exposure of the patients to various antibiotics, though during the period when the isolates were collected, tigecycline was not used in China. MIC values of polymyxin B and tigecycline for porin-deficient strains were similar to those where porins are normally expressed, suggesting that activities of both antibiotics were not affected by porin loss, which was also described previously (Conejo et al., 2008) . Tigecycline resistance in A. baumannii and low-grade resistance in members of the family Enterobacteriaceae have been attributed to an efflux pump system (Giske et al., 2008; Hornsey et al., 2010) . The mechanisms of tigecycline resistance, especially that for the high-level resistance in our isolates, require further studies.
